RA Resource Center
We are pleased to invite you to explore The Rheumatologist’s 2020 coverage of rheumatoid arthritis or systemic lupus erythematosus or gout sessions at ACR Convergence 2020, plus our collection of research reviews, case reports, and clinical articles on advances in the diagnosis and management of rheumatoid arthritis or systemic lupus erythematosus or gout.
Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
Physical Activity, Exercise Can Benefit Patients with RA
Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab
Advances in Precision Immunology Require Precision Controls to Further Research
Accelerating Medicines Partnership Shares Its Progress on RA/Lupus Network
Effectiveness of Tofacitinib with Methotrexate, Adalimumab Therapy Evaluated in Patients with RA
Abatacept Approved for Psoriatic Arthritis in Adults; Sirukumab Approval Stalls
Opioid Use in U.S. RA Patients
Gut Microbe, Prevotella copri, Implicated in RA Pathogenesis
- 1
- 2
- 3
- …
- 9
- Next Page »